Articles from Tremont AI

Tremont AI Announces New Research Collaboration to Develop AI Models for Preclinical Safety Assessment
Tremont AI, an AI company specialized in preclinical drug safety, today announced a research collaboration with AstraZeneca to develop and evaluate AI solutions for accelerated safety screening in preclinical toxicologic pathology studies.
By Tremont AI · Via Business Wire · October 27, 2026
Tremont AI Emerges from Stealth to Bring Multimodal AI to Preclinical Drug Safety
Tremont AI, a biomedical AI company focused on preclinical drug safety, today emerged from stealth. The company is developing multimodal foundation models and AI agents to help scientists analyze and interpret evidence across preclinical safety studies.
By Tremont AI · Via Business Wire · September 29, 2026